Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19


Risk factors for osteoporosis in inflammatory bowel disease patients.

Lima CA, Lyra AC, Rocha R, Santana GO.

World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):210-218. Review.


Nutrient intake and bone mineral density by nutritional status in patients with inflammatory bowel disease.

Lim H, Kim HJ, Hong SJ, Kim S.

J Bone Metab. 2014 Aug;21(3):195-203. doi: 10.11005/jbm.2014.21.3.195. Epub 2014 Aug 31.


Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.

Nguyen GC, Devlin SM, Afif W, Bressler B, Gruchy SE, Kaplan GG, Oliveira L, Plamondon S, Seow CH, Williams C, Wong K, Yan BM, Jones J.

Can J Gastroenterol Hepatol. 2014 May;28(5):275-85. Review.


Bone loss in patients with the ileostomy and ileal pouch for inflammatory bowel disease.

Gupta S, Shen B.

Gastroenterol Rep (Oxf). 2013 Nov;1(3):159-65. doi: 10.1093/gastro/got030.


Bone mass and mineral metabolism alterations in adult celiac disease: pathophysiology and clinical approach.

Di Stefano M, Mengoli C, Bergonzi M, Corazza GR.

Nutrients. 2013 Nov 22;5(11):4786-99. doi: 10.3390/nu5114786. Review.


Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.

Gregson CL, Dennison EM, Compston JE, Adami S, Adachi JD, Anderson FA Jr, Boonen S, Chapurlat R, Díez-Pérez A, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Watts NB, Wyman A, Cooper C; GLOW Investigators.

Osteoporos Int. 2014 Jan;25(1):85-95. doi: 10.1007/s00198-013-2438-y. Epub 2013 Jul 25.


Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Yang Z, Clark N, Park KT.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21.


Rickets-vitamin D deficiency and dependency.

Sahay M, Sahay R.

Indian J Endocrinol Metab. 2012 Mar;16(2):164-76. doi: 10.4103/2230-8210.93732.


Extraintestinal manifestations of inflammatory bowel disease.

Levine JS, Burakoff R.

Gastroenterol Hepatol (N Y). 2011 Apr;7(4):235-41.


Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.

Ghishan FK, Kiela PR.

Am J Physiol Gastrointest Liver Physiol. 2011 Feb;300(2):G191-201. doi: 10.1152/ajpgi.00496.2010. Epub 2010 Nov 18. Review.


Osteoporosis and gastrointestinal disease.

Katz S, Weinerman S.

Gastroenterol Hepatol (N Y). 2010 Aug;6(8):506-17.


Risk of diagnosed fractures in children with inflammatory bowel diseases.

Kappelman MD, Galanko JA, Porter CQ, Sandler RS.

Inflamm Bowel Dis. 2011 May;17(5):1125-30. doi: 10.1002/ibd.21472. Epub 2010 Sep 24.


The effect of physician workload on an educational intervention to increase vitamin D screening.

Kramm H, Gangnon R, Jones AN, Linzer M, Hansen KE.

WMJ. 2010 Jun;109(3):136-41.


Bone health in a tertiary-care gastroenterology and hepatology population.

Long MD, Thiny MT, Sandler RS, Gangarosa LM.

Dig Dis Sci. 2010 Aug;55(8):2263-9. doi: 10.1007/s10620-010-1130-8. Epub 2010 Feb 2.


Exercise and inflammatory bowel disease.

Narula N, Fedorak RN.

Can J Gastroenterol. 2008 May;22(5):497-504. Review.


Celiac disease manifested by polyneuropathy and swollen ankles.

Djuric Z, Kamenov B, Katic V.

World J Gastroenterol. 2007 May 14;13(18):2636-8.


Extraintestinal manifestations and complications in inflammatory bowel diseases.

Rothfuss KS, Stange EF, Herrlinger KR.

World J Gastroenterol. 2006 Aug 14;12(30):4819-31. Review.


The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.

Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H.

Gut. 2005 Apr;54(4):479-87.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk